Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SensiVida Medical Systems was a medical technology company focused on developing minimally invasive diagnostic devices using proprietary microsystems and nanotechnology. The company's core platform utilized an optical-digital sensing system combined with microneedle technology to automate bio-sensing and data acquisition while reducing patient pain. Its primary product, the Digital Allergy Test System, aimed to modernize traditional allergy testing by providing standardized, digital results that could be integrated into electronic medical records. SensiVida also developed a pipeline of diagnostic applications for glucose monitoring, blood coagulation, and cholesterol. Despite advancing its allergy test into clinical trials, the company is no longer active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SensiVida Medical Systems.